Eva Fortea Verdejo

Stock Analyst

(n/a)
# 4,648
Out of 4,648 analysts
3
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Eva Fortea Verdejo

Arcus Biosciences
Oct 8, 2024
Initiates: Overweight
Price Target: $29
Current: $15.50
Upside: +87.10%
iTeos Therapeutics
Aug 13, 2024
Initiates: Overweight
Price Target: $31
Current: $8.81
Upside: +251.87%
Kiniksa Pharmaceuticals International,
May 3, 2024
Initiates: Overweight
Price Target: $34
Current: $22.48
Upside: +51.28%